US Patent Issued to Agilent Technologies, MERCK SHARP & DOHME on Jan. 20 for "Scoring methods for anti-PD therapy eligibility and compositions for performing same" (California, New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,702, issued on Jan. 20, was assigned to Agilent Technologies Inc. (Santa Clara, Calif.) and MERCK SHARP & DOHME LLC (Rahway, N.J.).

"Scoring methods for anti-PD therapy eligibility and compositions for performing same" was invented by Karina Kulangara (Carpinteria, Calif.), Nancy Zhang (Thousand Oaks, Calif.), David Stanforth (Carpinteria, Calif.), Greg Angelides (Philadelphia), Stephanie Waldroup (Santa Barbara, Calif.) and Kenneth Emancipator (Bernardsville, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the present disclosure provide methods for determining the eligibility of a subject having a malignancy for treatment with an ant...